Stockscreener 앱 받기
0.196
1.51%
-0.003
Coeptis Therapeutics Holdings Inc 주식(COEP)의 최신 뉴스
Armistice Capital, LLC's Strategic Acquisition in Coeptis Therap - GuruFocus.com
Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development - Quantisnow
Coeptis broadens NK cell tech license for emergency use - Investing.com India
Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use - Citizentribune
Coeptis Therapeutics' Chief Scientific and Medical Officer to Present at Upcoming Fall Conferences, Highlighting Progress in Universal Cell Therapy - Longview News-Journal
A Tale of Resilience: Coeptis Therapeutics Holdings Inc Amid Stock Market Turbulence - The InvestChronicle
Is Coeptis Therapeutics Holdings Inc (COEP) a good investment opportunity? - US Post News
Coeptis Therapeutics Holdings Inc (COEP)’s stock price range in the last year - US Post News
Coeptis Therapeutics appoints new auditor for fiscal year 2024 By Investing.com - Investing.com South Africa
Coeptis Therapeutics appoints new auditor for fiscal year 2024 - Investing.com
Market Insights: Coeptis Therapeutics Holdings Inc (COEP)’s Notable Gain of 5.00, Closing at 0.17 - The Dwinnex
CERo Therapeutics Hldgs (NASDAQ:CERO) Stock Quotes, Forecast and News Summary - Benzinga
COEP stock touches 52-week low at $0.17 amid market challenges - Investing.com Canada
Cepton (NASDAQ:CPTN) vs. China Zenix Auto International (OTCMKTS:ZXAIY) Head-To-Head Analysis - Defense World
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by Rhumbline Advisers - Defense World
Is Cooper Companies Stock Outperforming The Nasdaq? - Barchart
FDA Approval Propels ZVRA To 52-week High, ADMA, CPRX, TVTX Also Reach New Peaks - Nasdaq
Tucows CEO Elliot Noss sells shares worth over $125k - Investing.com India
Choreo LLC Purchases Shares of 23,033 Coty Inc. (NYSE:COTY) - Defense World
Coeptis Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing - The Malaysian Reserve
Coherent Corp (COHR)’s Market Momentum: Closing Strong at 80.98, Up 3.93 - The Dwinnex
Coeptis Therapeutics secures Nasdaq listing extension - Investing.com India
Coeptis Therapeutics secures Nasdaq listing extension By Investing.com - Investing.com Australia
Exicure Shares More Than Double After Nasdaq Listing Extension - MarketWatch
Exicure Stock Is Soaring After The Bell: What's Driving The Action? - Benzinga
COHR’s Wild Ride: Up 82.75% – What’s Next for COHR? - The InvestChronicle
Cogent Biosciences (NASDAQ:COGT) Stock Price Up 4.1% - Defense World
Choreo LLC Takes $333,000 Position in The Cooper Companies, Inc. (NASDAQ:COO) - Defense World
Quest Partners LLC Acquires New Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Exicure Inc (XCUR) rating downgrades by Chardan Capital Markets - Knox Daily
Cogent Biosciences Inc (COGT) stock analysis: A comprehensive overview - US Post News
Coeptis Therapeutics Announces Research Involving SNAP-CAR Accep - GuruFocus.com
Choreo LLC Buys Shares of 6,902 Ziff Davis, Inc. (NASDAQ:ZD) - Defense World
Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 4.1% - Defense World
Is Cogent Biosciences Inc (COGT) positioned for future growth? - SETE News
Quarterly Metrics: Quick and Current Ratios for Cogent Biosciences Inc (COGT) - The Dwinnex
Coherent Corp (COHR) receives a Buy rating from Needham - Knox Daily
Bank of New York Mellon Corp Buys 45,770 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Coeptis Therapeutics progresses in cell therapy trials - Investing.com
Coeptis Therapeutics progresses in cell therapy trials By Investing.com - Investing.com UK
Coeptis Therapeutics Chief Executive Officer, Dave Mehalick, Updates and Outlines Strategic Vision in Letter to Shareholders - PR Newswire
Coeptis Therapeutics (NASDAQ:COEP) Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS - Defense World
Coeptis Therapeutics to Present at the Emerging Growth Conferenc - GuruFocus.com
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Sees Large Growth in Short Interest - Defense World
Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting - Longview News-Journal
Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting - Longview News-Journal
Coeptis Therapeutics retracts financial statements due to errors - Investing.com
Daily Progress: Coeptis Therapeutics Holdings Inc (COEP) Drop -0.88, Closing at 0.20 - The Dwinnex
Holdings of Coeptis Therapeutics Holdings Inc (COEP) are aligned with the stars - SETE News
Riding the Waves: A Guide to Investing in COEP Stock - The InvestChronicle
Was anything negative for Coeptis Therapeutics Holdings Inc (COEP) stock last session? - US Post News
Market Insight: Coeptis Therapeutics Holdings Inc (COEP)’s Notable Drop, Closing at 0.24 - The Dwinnex
Critical Survey: Vir Biotechnology (NASDAQ:VIR) & Coeptis Therapeutics (NASDAQ:COEP) - Defense World
A Guide To The Risks Of Investing In Coeptis Therapeutics Holdings Inc (COEP) – Knox Daily - Knox Daily
LADENBURG THALM/SH SH Lowers Coeptis Therapeutics (NASDAQ:COEP) to Hold - Defense World
Coeptis Therapeutics Closes $4.3 Million Series A - citybiz
Coeptis Therapeutics Closes $4.3M Series A Funding - FinSMEs
Coeptis Therapeutics closes on $4.3 million Series APittsburgh Business Times - The Business Journals
Coeptis Therapeutics Holdings, Inc. Announces Pricing of $3.5 Million Underwritten Offering - Quantisnow
Coeptis Therapeutics Holdings, Inc. Announces Closing of $3.5 Million Underwritten Offering - Quantisnow
Coeptis Therapeutics Appoints Colleen Delaney, MD, as Chief Scientific and Medical Officer - Quantisnow
Coeptis Therapeutics to Present at the Emerging Growth Conference - Quantisnow
Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for ... - Quantisnow
Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering - PR Newswire
COEP’s Stochastic Averages Dip: Analyzing Coeptis Therapeutics Holdings Inc’s Stock Performance - The InvestChronicle
3.66%
1.11%
자본화:
|
볼륨(24시간):